Balchem (BCPC) Earnings Analysis
Balchem (BCPC) next reports earnings on 2026-07-31, consensus EPS 1.27 USD. Last quarter (2026-04-30) it missed with EPS 1.25 USD vs 1.33 USD est (-6%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E 33.08.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BCPC next report earnings?
| Next earnings date | 2026-07-31 |
|---|---|
| Consensus EPS estimate | 1.27 USD |
| Revenue estimate | 0.27B |
BCPC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 1.25 USD | 1.33 USD | -6% | Miss |
| 2026-02-20 | 1.31 USD | 1.29 USD | +1.6% | Beat |
| 2025-10-21 | 1.35 USD | 1.36 USD | -0.7% | Miss |
| 2025-07-31 | 1.27 USD | 1.25 USD | +1.6% | Beat |
| 2025-04-24 | 1.22 USD | 1.25 USD | -2.4% | Miss |
| 2025-02-21 | 1.03 USD | 1.11 USD | -7.2% | Miss |
| 2024-10-25 | 1.13 USD | 1.11 USD | +1.8% | Beat |
| 2024-07-26 | 1.09 USD | 1.03 USD | +5.8% | Beat |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
BCPC valuation and analyst view
| Trailing P/E | 33.08 |
|---|---|
| Trailing EPS | 4.896 USD |
| Price / book | 4.07 |
| Dividend yield | 0.59% |
| Market cap | 5.18B |
| Analyst consensus | Buy (6 buy / 4 hold / 0 sell) |
| Avg price target | 175.5 USD |
Related research pages
Frequently asked questions
When is Balchem (BCPC)'s next earnings date?
Balchem is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 1.27 USD and revenue estimate of 0.27B.
Did BCPC beat earnings last quarter?
In its 2026-04-30 report, BCPC posted EPS of 1.25 USD versus a 1.33 USD estimate — a miss of 6%.
What is BCPC's earnings track record?
Over the last 8 reported quarters with consensus data, BCPC beat estimates 4 times (50%).
What is BCPC's current P/E ratio and EPS?
BCPC trades at a trailing P/E of 33.08 on trailing EPS of 4.896450253995788 USD.
What do analysts rate BCPC?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell). Average 12-month price target: 175.5 USD.